First Bank & Trust »

Cytokinetics shares owned by First Bank & Trust

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by First Bank & Trust from 13F filings

Historical chart of First Bank & Trust investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by First Bank & Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by First Bank & Trust

Quarter filed Position value Share count Share price at filing
2024-03-31 $453k 6.5k 70.11

More positions owned by First Bank & Trust

Van Ttl Stk Mkt Equities (VTI)
Vanguard FTSE Dev Equities (VEA)
iShares Core Equities (AGG)
Vanguard FTSE Emg Equities (VWO)
Vanguard Index Fd Et Equities (VOO)
Microsoft Corp Equities (MSFT)
iShares Core S&P Scp Equities (IJR)
Big Sioux Financial Equities
iShares Tr Core S&P Equities (IJH)
Daktronics Equities (DAKT)
Vanguard S&P 500 Val Equities (VOOV)
Vanguard Sp 600 Val Equities (VIOV)
Nvidia Corporation Equities (NVDA)
Total Sa- Equities (TTE)
S&P 500 Catholic Equities (CATH)

View all positions for First Bank & Trust

Top funds holding Cytokinetics

Vanguard Group
Wellington Management Company
Caption Management
T. Rowe Price Associates
Henderson Group
Boxer Capital
Citadel Advisors
Partner Fund Management
Logos Global Management
Lord, Abbett & Co
Millennium Management
Artal Group
Barclays
Gts Securities
Goldman Sachs Group

View all funds holding Cytokinetics